Prostin E2 Tablets 0.5 mg (Dinoprostone TABLET) 0.5 MG

Prostin E2 Tablets 0.5 mg contain dinoprostone, a medication used for specific reproductive health conditions. This oral tablet is manufactured by Pfizer Canada ULC and is available in packs of 10.

Strength

0.5 MG

Pack Size

Manufacturer / TM Owner

PFIZER CANADA ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Prostin E2 Tablets are primarily used for reproductive health purposes. Dinoprostone, the active ingredient, is often utilized in the management of certain conditions related to the uterus. It is important to consult a healthcare provider to understand what is dinoprostone used for and how it may apply to your specific situation.

Side Effects

Common effects of Prostin E2 Tablets may include gastrointestinal discomfort, nausea, or cramping. Individual responses can vary, and not everyone will experience these effects. Always discuss potential side effects with a healthcare professional.

Precautions & Warnings

Handle Prostin E2 Tablets with care, following the guidance of a healthcare provider. Store the medication as directed, typically at room temperature, and keep it out of reach of children. Always adhere to the prescribed usage to minimize potential risks.

Avoid Interactions

Prostin E2 Tablets may interact with other medications, including certain pain relievers or hormonal treatments. It is crucial to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare professional.

Frequently Asked Questions

Diprostone is used for specific reproductive health conditions, often related to the uterus. Consult a healthcare provider for detailed information.

Store Prostin E2 Tablets at room temperature, away from moisture and heat, and keep them out of reach of children.

Common side effects may include gastrointestinal discomfort, nausea, or cramping. Individual experiences can vary.

Prostin E2 Tablets may interact with other medications. Always consult a healthcare provider before combining with other treatments.

Discuss alcohol consumption with your healthcare provider, as it may affect the efficacy or safety of Prostin E2 Tablets.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.